PXAI Audio Feed
25/04 14:00 statnews.com

Opinion: The podcast telling the stories behind Ambien, Ozempic, EpiPens, and other game-changing drugs

POLITICSFIRST OPINION PODCASTFIRST OPINIONPHARMACEUTICALSDRUG DEVELOPMENTPUBLIC HEALTH
24/04 20:50 statnews.com

STAT+: A biotech VC on what Eli Lilly saw in a struggling cancer startup for $3.2B

THE READOUT LOUDPHARMACEUTICAL INDUSTRYELI LILLYBIOTECHPOLITICSVENTURE CAPITAL
24/04 16:19 statnews.com

STAT+: Sanofi MS drug gets positive review in Europe following FDA

DRUG DEVELOPMENTTHE READOUTPOLITICSDRUG PRICINGRESEARCHPHARMACEUTICALS
24/04 11:30 statnews.com

Psychedelics get a boost from the White House

PUBLIC HEALTHPOLICYMENTAL HEALTHPHARMACEUTICALSSTATUS REPORTPSYCHEDELICS
24/04 01:52 pbs.org

WATCH: Trump unveils deal with Regeneron to lower its drug prices for Medicaid

DONALD TRUMP NEWSPHARMACEUTICAL COMPANIESPOLITICSDRUG PRICES
23/04 21:31 washingtonexaminer.com

WATCH LIVE: White House announces pharmaceutical deal with Regeneron

PHARMACEUTICAL INDUSTRYDONALD TRUMPAFFORDABILITYWHITE HOUSEPOLITICSHEALTHCARE
23/04 19:55 statnews.com

STAT+: Legislatures in Colorado and Virginia resist moves to constrain drug affordability boards

STAT+PHARMALOTPOLITICSBIOTECHNOLOGYDRUG PRICINGPHARMACEUTICALS
23/04 17:47 statnews.com

STAT+: RFK Jr. backs off some MAHA issues

BUSINESSHEALTHPHARMAPHARMACEUTICALSCONGRESSSTAT+
23/04 16:39 statnews.com

STAT+: AMA calls for regulatory crackdown on chatbots, wellness AI

HEALTH TECH NEWSLETTERSTAT+PHARMACEUTICALSPOLITICSHEALTH TECH
23/04 16:39 statnews.com

STAT+: AMA calls for regulatory crackdown on chatbots, wellness AI

HEALTH TECH NEWSLETTERSTAT+PHARMACEUTICALSPOLITICSHEALTH TECH
Comments
Loading...
0